BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33066437)

  • 1. The Acute Phase Reaction and Its Prognostic Impact in Patients with Head and Neck Squamous Cell Carcinoma: Single Biomarkers Including C-Reactive Protein Versus Biomarker Profiles.
    Aarstad HH; Moe SEE; Bruserud Ø; Lybak S; Aarstad HJ; Tvedt THA
    Biomedicines; 2020 Oct; 8(10):. PubMed ID: 33066437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Biological Context of C-Reactive Protein as a Prognostic Marker in Renal Cell Carcinoma: Studies on the Acute Phase Cytokine Profile.
    Aarstad HH; Guðbrandsdottir G; Hjelle KM; Bostad L; Bruserud Ø; Tvedt THA; Beisland C
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32707675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma IL-1 and IL-6 Family Cytokines with Soluble Receptor Levels at Diagnosis in Head and Neck Squamous Cell Carcinoma: High Levels Predict Decreased Five-Year Disease-Specific and Overall Survival.
    Aarstad HH; Moe SEE; Lybak S; Bruserud Ø; Tvedt THA; Aarstad HJ
    Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.
    Aarstad HJ; Vintermyr OK; Ulvestad E; Aarstad HH; Kross KW; Heimdal JH
    APMIS; 2015 Apr; 123(4):305-14. PubMed ID: 25801083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
    Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
    Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of key genes and signal pathways of human papilloma virus-related head and neck squamous cell carcinoma].
    Wang KP; Yuan YJ; Zhu JQ; Li BL; Zhang TT
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2020 Aug; 55(8):571-577. PubMed ID: 32842349
    [No Abstract]   [Full Text] [Related]  

  • 7. FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
    Koole K; Brunen D; van Kempen PM; Noorlag R; de Bree R; Lieftink C; van Es RJ; Bernards R; Willems SM
    Clin Cancer Res; 2016 Aug; 22(15):3884-93. PubMed ID: 26936917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of proinflammatory and proangiogenic cytokines in patients with head and neck cancer.
    Chen Z; Malhotra PS; Thomas GR; Ondrey FG; Duffey DC; Smith CW; Enamorado I; Yeh NT; Kroog GS; Rudy S; McCullagh L; Mousa S; Quezado M; Herscher LL; Van Waes C
    Clin Cancer Res; 1999 Jun; 5(6):1369-79. PubMed ID: 10389921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.
    Fakhry C; Westra WH; Li S; Cmelak A; Ridge JA; Pinto H; Forastiere A; Gillison ML
    J Natl Cancer Inst; 2008 Feb; 100(4):261-9. PubMed ID: 18270337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined C-Reactive Protein and Novel Inflammatory Parameters as a Predictor in Cancer-What Can We Learn from the Hematological Experience?
    Bruserud Ø; Aarstad HH; Tvedt THA
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32707721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Impact of Serum CRP Level in Head and Neck Squamous Cell Carcinoma.
    Zhang Y; Gu D
    Front Oncol; 2022; 12():889844. PubMed ID: 35847918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LCL161, a SMAC-mimetic, Preferentially Radiosensitizes Human Papillomavirus-negative Head and Neck Squamous Cell Carcinoma.
    Yang L; Kumar B; Shen C; Zhao S; Blakaj D; Li T; Romito M; Teknos TN; Williams TM
    Mol Cancer Ther; 2019 Jun; 18(6):1025-1035. PubMed ID: 31015310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNAs as new biomarkers for human papilloma virus related head and neck cancers.
    Wang Y; Wang J; Huang Y
    Cancer Biomark; 2015; 15(3):213-8. PubMed ID: 25769448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Head and neck squamous cell carcinoma: Genomics and emerging biomarkers for immunomodulatory cancer treatments.
    Solomon B; Young RJ; Rischin D
    Semin Cancer Biol; 2018 Oct; 52(Pt 2):228-240. PubMed ID: 29355614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Relationship between human papilloma virus infection and expression of p16 and EGFR in head and neck squamous cell carcinoma and their prognostic significance].
    Ma L; Wang D; Wufuer A; Wu R; Zhang S; Wang R
    Zhonghua Zhong Liu Za Zhi; 2014 Jan; 36(1):23-8. PubMed ID: 24685082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection.
    López RV; Levi JE; Eluf-Neto J; Koifman RJ; Koifman S; Curado MP; Michaluart-Junior P; Figueiredo DL; Saggioro FP; de Carvalho MB; Kowalski LP; Abrahão M; de Góis-Filho F; Tajara EH; Waterboer T; Boffetta P; Brennan P; Wünsch-Filho V
    Cancer Causes Control; 2014 Apr; 25(4):461-71. PubMed ID: 24474236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small molecule-based chemotherapeutic approach in p16-positive and -negative HNSCC in vitro.
    Aderhold C; Faber A; Grobschmidt GM; Chakraborty A; Bockmayer A; Umbreit C; Birk R; Stern-Straeter J; Hörmann K; Schultz JD
    Anticancer Res; 2013 Dec; 33(12):5385-93. PubMed ID: 24324073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Stem Cell Factor HMGA2 Is Expressed in Non-HPV-Associated Head and Neck Squamous Cell Carcinoma and Predicts Patient Survival of Distinct Subsites.
    Günther K; Foraita R; Friemel J; Günther F; Bullerdiek J; Nimzyk R; Markowski DN; Behrens T; Ahrens W
    Cancer Epidemiol Biomarkers Prev; 2017 Feb; 26(2):197-205. PubMed ID: 27742669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interplay between HPV and host immunity in head and neck squamous cell carcinoma.
    Andersen AS; Koldjaer Sølling AS; Ovesen T; Rusan M
    Int J Cancer; 2014 Jun; 134(12):2755-63. PubMed ID: 23913554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TMEM16A/ANO1 is differentially expressed in HPV-negative versus HPV-positive head and neck squamous cell carcinoma through promoter methylation.
    Dixit R; Kemp C; Kulich S; Seethala R; Chiosea S; Ling S; Ha PK; Duvvuri U
    Sci Rep; 2015 Nov; 5():16657. PubMed ID: 26563938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.